Overview

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It is designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Abbott
Treatments:
Amoxicillin
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefdinir
Cephalosporins
Criteria
Inclusion Criteria:

- Female or male child age 4 through 8 years in good general health.

- Minimum weight of 16.3 kg (36 lb).

- Willing to comply with appropriate instructions provided to complete the study.

- Written informed consent from parent/legal guardian.

Exclusion Criteria:

- Current medical condition, that in the opinion of the Investigator or designee, could
interfere with the ability to discriminate taste (e.g., common cold, sinus infection,
bronchial infection, etc.).

- History of allergic reaction to cefdinir, prescription (e.g. penicillins or
cephalosporins) and/or OTC medications, and/or food products.

- History of significant medical condition (e.g., GI disorders, hematological or
bleeding disorders, renal or hepatic diseases).

- Use of any oral medication, vitamins or herbal supplements within 6 hours prior to
tasting.

- Temperature > than 99.2°F.

- Participation in a clinical or marketing research study within the past 3 months.

- Sibling of another subject on the study, or living in the same household as another
subject that has participated in a clinical or marketing research study within the
past 3 months.

- Family member or close friend employed by an advertising agency, market research
company and/or a company that processes or manufacturers medical or health care
products.